首页> 美国卫生研究院文献>The Journal of Clinical Investigation >Characterization of a carboxyterminal peptide fragment of the human choriogonadotropin beta-subunit excreted in the urine of a woman with choriocarcinoma.
【2h】

Characterization of a carboxyterminal peptide fragment of the human choriogonadotropin beta-subunit excreted in the urine of a woman with choriocarcinoma.

机译:绒毛膜癌女性尿液中排泄的人绒毛膜促性腺激素β亚基的羧基末端肽片段的特征。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We have observed low-molecular weight carboxyterminal fragments of the human choriogonadotropin (hCG) beta-subunit in the urines of several women with choriocarcinoma, and we have characterized one fragment in detail. Its apparent molecular weight by gel chromatography on Sephadex G-100 was 14,200. The fragment was not adsorbed to concanavalin A-Sepharose, indicating that it lacked the asparagine-linked carbohydrate groups of intact hCG beta. It was active in radioimmunoassays (RIA) using antisera either to the hCG beta carboxyterminal peptide (CTP) or to the desialylated hCG beta CTP (hCG beta as-CTP), indicating the presence of not only the hCG beta carboxyterminus but also desialylated O-serine-linked carbohydrate side chains on the fragment. It lacked luteinizing hormone/choriogonadotropin radioreceptor activity and hCG beta conformational immunoreactivity (SB6 RIA). On Sephadex G-100 gel chromatography, the elution profiles of this fragment and the hCG beta as-CTP(115-145) prepared by trypsin digestion of as-hCG were essentially indistinguishable (apparent molecular weights 14,200 and 14,000, respectively). The immunological characteristics of the fragment in both hCG beta CTP and hCG beta as-CTP RIA were indistinguishable from those of the hCG beta as-CTP(115-145) glycopeptide. Carboxyterminal fragments of hCG beta were evident in urine specimens obtained from 10 of 11 patients with choriocarcinoma but not in those obtained from normal subjects who were given an intravenous infusion of highly purified hCG. Of six pregnant women, only the one at term excreted carboxyterminal fragments of hCG beta and then only in trace amounts. We conclude that hCG beta carboxyterminal fragments, including one that is indistinguishable from the tryptic glycopeptide hCG beta as-CTP(115-145), can occur naturally in the urine of patients with choriocarcinoma.
机译:我们已经观察到几例绒毛膜癌女性尿液中人绒毛膜促性腺激素(hCG)β亚基的低分子量羧基末端片段,并且我们已经详细描述了一个片段。通过凝胶色谱在Sephadex G-100上的表观分子量为14,200。该片段未吸附至伴刀豆球蛋白A-Sepharose,表明它缺少完整hCGβ的天冬酰胺连接的碳水化合物基团。它在使用hCGβ羧基末端肽(CTP)或去唾液酸化hCGβCTP(hCG beta as-CTP)抗血清的放射免疫分析(RIA)中具有活性,表明不仅存在hCGβ羧基末端,而且存在去唾液酸化O-片段上的丝氨酸连接的碳水化合物侧链。它缺乏黄体生成素/促性腺激素放射性受体活性和hCGβ构象免疫反应性(SB6 RIA)。在Sephadex G-100凝胶色谱上,该片段和通过胰蛋白酶消化as-hCG制备的hCG beta as-CTP(115-145)的洗脱曲线基本无法区分(表观分子量分别为14,200和14,000)。 hCG beta CTP和hCG beta as-CTP RIA中的片段的免疫学特征与hCG beta as-CTP(115-145)糖肽的免疫学特征没有区别。 hCGβ的羧基末端片段在从11名绒癌患者中的10个获得的尿液样本中很明显,但在从接受静脉内注射高纯度hCG的正常受试者获得的尿液样本中却没有。在六名孕妇中,只有一个足月的孕妇排泄了hCGβ的羧基末端片段,然后仅以微量排出。我们得出的结论是,绒毛膜绒毛膜癌患者的尿液中自然会出现hCGβ羧基末端片段,包括与胰蛋白酶糖肽hCGβas-CTP(115-145)难以区分的片段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号